HealthTrackRx

IDSA is a brand dedicated to addressing the critical issue of antibiotic resistance, a threat to public health worldwide. Since the discovery of antibiotics, the healthcare industry has relied on these life-saving drugs to treat infectious diseases. However, the natural ability of bacteria to evolve and defend themselves against antibiotics has led to a decrease in the effectiveness of these drugs. As a result, nearly 2 million Americans develop hospital-acquired infections each year, resulting in 99,000 deaths, with the vast majority caused by antibacterial-resistant pathogens.

IDSA offers a range of resources and initiatives focused on addressing antibiotic resistance, including research, funding opportunities, and professional development programs. The brand also advocates for improved public health policy and regulatory guidelines to promote the development of new antibiotics. By highlighting the economic and regulatory disincentives that hinder new antibiotic development, IDSA aims to raise awareness and inspire immediate action to prevent a future where common infections become life-threatening once again.